Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00005064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT06817720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
ClinicalTrials.gov study NCT01126892. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
ClinicalTrials.gov study NCT04681820. IPD Sharing: NO. Countries: 1. Publications: 0.
FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05152537. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Advanced Practice Nurse's Management of Patients with Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT06082804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
ClinicalTrials.gov study NCT01746836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
ClinicalTrials.gov study NCT05439889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
ClinicalTrials.gov study NCT03933852. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions
ClinicalTrials.gov study NCT02103322. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
ClinicalTrials.gov study NCT02977312. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00162513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach
ClinicalTrials.gov study NCT03540654. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00964873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
ClinicalTrials.gov study NCT04925141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)
ClinicalTrials.gov study NCT02034656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
ClinicalTrials.gov study NCT01188889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regional Central Database Recording of Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02869256. IPD Sharing: NO. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00002890. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.